The Trump administration’s December 2025 executive order directed expedited rulemaking to move marijuana from Schedule I to Schedule III under the Controlled Substances Act. In April 2026 the Department of Justice and DEA implemented an immediate order reclassifying FDA-approved cannabis products and state-licensed medical marijuana to Schedule III, while terminating prior proceedings and launching a compressed administrative hearing process. That hearing is scheduled to begin June 29, 2026, with firm deadlines intended to complete broader rescheduling review more rapidly than the multi-year timeline that began under the prior administration. These steps have shifted trader focus to whether the DEA can finalize full Schedule III placement before key resolution dates, with outcomes hinging on the hearing record, any subsequent rulemaking, and potential litigation or procedural delays.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว$761,725 ปริมาณ
Mar 31, 2026
June 30
3%
December 31
31%
$761,725 ปริมาณ
June 30
$338,273 ปริมาณ
3%
December 31
$158,570 ปริมาณ
31%
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.The Trump administration’s December 2025 executive order directed expedited rulemaking to move marijuana from Schedule I to Schedule III under the Controlled Substances Act. In April 2026 the Department of Justice and DEA implemented an immediate order reclassifying FDA-approved cannabis products and state-licensed medical marijuana to Schedule III, while terminating prior proceedings and launching a compressed administrative hearing process. That hearing is scheduled to begin June 29, 2026, with firm deadlines intended to complete broader rescheduling review more rapidly than the multi-year timeline that began under the prior administration. These steps have shifted trader focus to whether the DEA can finalize full Schedule III placement before key resolution dates, with outcomes hinging on the hearing record, any subsequent rulemaking, and potential litigation or procedural delays.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
ตลาดเปิดเมื่อ: Feb 7, 2026, 5:04 PM ET
ปริมาณการซื้อขาย
$761,725วันสิ้นสุด
Mar 31, 2026ตลาดเปิดเมื่อ
Feb 7, 2026, 5:04 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.The Trump administration’s December 2025 executive order directed expedited rulemaking to move marijuana from Schedule I to Schedule III under the Controlled Substances Act. In April 2026 the Department of Justice and DEA implemented an immediate order reclassifying FDA-approved cannabis products and state-licensed medical marijuana to Schedule III, while terminating prior proceedings and launching a compressed administrative hearing process. That hearing is scheduled to begin June 29, 2026, with firm deadlines intended to complete broader rescheduling review more rapidly than the multi-year timeline that began under the prior administration. These steps have shifted trader focus to whether the DEA can finalize full Schedule III placement before key resolution dates, with outcomes hinging on the hearing record, any subsequent rulemaking, and potential litigation or procedural delays.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
ปริมาณการซื้อขาย
$761,725วันสิ้นสุด
Mar 31, 2026ตลาดเปิดเมื่อ
Feb 7, 2026, 5:04 PM ETResolver
0x65070BE91...The Trump administration’s December 2025 executive order directed expedited rulemaking to move marijuana from Schedule I to Schedule III under the Controlled Substances Act. In April 2026 the Department of Justice and DEA implemented an immediate order reclassifying FDA-approved cannabis products and state-licensed medical marijuana to Schedule III, while terminating prior proceedings and launching a compressed administrative hearing process. That hearing is scheduled to begin June 29, 2026, with firm deadlines intended to complete broader rescheduling review more rapidly than the multi-year timeline that began under the prior administration. These steps have shifted trader focus to whether the DEA can finalize full Schedule III placement before key resolution dates, with outcomes hinging on the hearing record, any subsequent rulemaking, and potential litigation or procedural delays.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย